Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis

Frontiers in Pharmacology

Volumn 5 JAN, Issue , 2014, Pages

  Habiel, David M ^a   Hogaboam, Cory ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

C C Chemokine receptor type 7 (CCR7); C C motif chemokine ligand 21 (CCL21); Glycoprotein 130 (gp130); Idiopathic pulmonary fibrosis (IPF); Interleukin 6 (IL6); Lung fibroblasts; Myofibroblasts; Toll like receptor 9 (TLR9)

Indexed keywords

EID: 84893467183     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00002     Document Type: Review

References (46)

1. Abe, R., Donnelly, S. C., Peng, T., Bucala, R., and Metz, C. N. (2001). Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 166, 7556-7562.
2. Andersson-Sjöland, A., De Alba, C. G., Nihlberg, K., Becerril, C., Ramírez, R., Pardo, A., et al. (2008). Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int. J. Biochem. Cell Biol. 40, 2129-2140. doi: 10.1016/j.biocel.2008.02.012.
3. Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., and Cerami, A. (1994). Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med. 1, 71-81.
4. Campbell, D. A., Poulter, L. W., Janossy, G., and du Bois, R. M. (1985). Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity. Thorax 40, 405-411. doi: 10.1136/thx.40.6.405.
5. Chesney, J., Metz, C., Stavitsky, A. B., Bacher, M., and Bucala, R. (1998). Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J. Immunol. 160, 419-425.
6. Choi, E. S., Pierce, E. M., Jakubzick, C., Carpenter, K. J., Kunkel, S. L., Evanoff, H., et al. (2006). Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia. J. Clin. Pathol. 59, 28-39. doi: 10.1136/jcp.2005.026872.
7. du Bois, R. M. (2010). Strategies for treating idiopathic pulmonary fibrosis. Nat. Rev. Drug Discov. 9, 129-140. doi: 10.1038/nrd2958.
8. Ewald, S. E., Engel, A., Lee, J., Wang, M., Bogyo, M., and Barton, G. M. (2011). Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase. J. Exp. Med. 208, 643-651. doi: 10.1084/jem.20100682.
9. Fang, L., and Hwang, S. T. (2009). "Roles for CCR7 in cancer biology," in Chemokine Receptors in Cancer, ed. A. M. Fulton (New York, NY: Humana Press), 93-108.
10. Hecker, L., and Thannickal, V. J. (2011). Non-resolving fibrotic disorders: idiopathic pulmonary fibrosis as a paradigm of impaired tissue regeneration. Am. J. Med. Sci. 341, 431-434. doi: 10.1097/MAJ.0b013e31821a9d66.
11. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., et al. (2000). A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745. doi: 10.1038/35047123.
12. Hogaboam, C. M., Murray, L., and Martinez, F. J. (2012). Epigenetic mechanisms through which Toll-like receptor-9 drives idiopathic pulmonary fibrosis progression. Proc. Am. Thorac. Soc. 9, 172-176. doi: 10.1513/pats.201201-002AW.
13. Kamimura, D., Ishihara, K., and Al, E. (2003). IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev. Physiol. Biochem. Pharmacol. 149, 1-38. doi: 10.1007/s10254-003-0012-2.
14. King, T. E. Jr. (2005). Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am. J. Respir. Crit. Care Med. 172, 268-279. doi: 10.1164/rccm.200503-483OE.
15. Knight, D. A., Ernst, M., Anderson, G. P., Moodley, Y. P., and Mutsaers, S. E. (2003). The role of gp130/IL-6 cytokines in the development of pulmonary fibrosis: critical determinants of disease susceptibility and progression? Pharmacol. Ther. 99, 327-338. doi: 10.1016/S0163-7258(03)00095-0.
16. Komenda, J., Barker, M., Kuvikova, S., De Vries, R., Mullineaux, C.W., Tichy, M., and Nixon, P.J. (2006) The FtsH protease, slr0228, is important for quality control of the thylakoid membrane of Synechocystis PCC6803. J. Biol. Chem. 281, 1145-1151. doi: 10.1074/jbc.M503852200.
17. Luckhardt, T. R., Coomes, S. M., Trujillo, G., Stoolman, J. S., Vannella, K. M., Bhan, U., et al. (2011). TLR9-induced interferon beta is associated with protection from gammaherpesvirus-induced exacerbation of lung fibrosis. Fibrogenesis Tissue Repair 4:18. doi: 10.1186/1755-1536-4-18.
18. Lund, J., Sato, A., Akira, S., Medzhitov, R., and Iwasaki, A. (2003). Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198, 513-520. doi: 10.1084/jem.20030162.
19. Marchal-Somme, J., Uzunhan, Y., Marchand-Adam, S., Valeyre, D., Soumelis, V., Crestani, B., et al. (2006). Cutting edge: non-proliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J. Immunol. 176, 5735-5739.
20. Mehrad, B., Burdick, M. D., Zisman, D. A., Keane, M. P., Belperio, J. A., and Strieter, R. M. (2007). Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem. Biophys. Res. Commun. 353, 104-108. doi: 10.1016/j.bbrc.2006.11.149.
21. Meneghin, A., Choi, E. S., Evanoff, H. L., Kunkel, S. L., Martinez, F. J., Flaherty, K. R., et al. (2008). TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation. Histochem. Cell Biol. 130, 979-992. doi: 10.1007/s00418-008-0466-z.
22. Moodley, Y. P., Misso, N. L., Scaffidi, A. K., Fogel-Petrovic, M., Mcanulty, R. J., Laurent, G. J., et al. (2003a). Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am. J. Respir. Cell Mol. Biol. 29, 490-498. doi: 10.1165/rcmb.2002-0262OC.
23. Moodley, Y. P., Scaffidi, A. K., Misso, N. L., Keerthisingam, C., Mcanulty, R. J., Laurent, G. J., et al. (2003b). Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/gp130-mediated cell signaling and proliferation. Am. J. Pathol. 163, 345-354. doi: 10.1016/S0002-9440(10)63658-9.
24. Mozaffarian, A., Brewer, A. W., Trueblood, E. S., Luzina, I. G., Todd, N. W., Atamas, S. P., et al. (2008). Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis. J. Immunol. 181, 7243-7253.
25. Nakashima, T., Yokoyama, A., Onari, Y., Shoda, H., Haruta, Y., Hattori, N., et al. (2008). Suppressor of cytokine signaling 1 inhibits pulmonary inflammation and fibrosis. J. Allergy Clin. Immunol. 121, 1269-1276. doi: 10.1016/j.jaci.2008.02.003.
26. Oak, S. R., Murray, L., Herath, A., Sleeman, M., Anderson, I., Joshi, A. D., et al. (2011). A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis. PLoS ONE 6:e21253. doi: 10.1371/journal.pone.0021253.
27. O'Donoghue, R. J., Knight, D. A., Richards, C. D., Prele, C. M., Lau, H. L., Jarnicki, A. G., et al. (2012). Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis. EMBO Mol. Med. 4, 939-591. doi: 10.1002/emmm.201100604.
28. Pechkovsky, D. V., Prêle, C. M., Wong, J., Hogaboam, C. M., Mcanulty, R. J., Laurent, G. J., et al. (2012). STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in uip/ipf. Am. J. Pathol. 180, 1398-1412. doi: 10.1016/j.ajpath.2011.12.022.
29. Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., et al. (2004). Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 114, 438-446.
30. Pierce, E. M., Carpenter, K., Jakubzick, C., Kunkel, S. L., Evanoff, H., Flaherty, K. R., et al. (2007a). Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21. Eur. Respir. J. 29, 1082-1093. doi: 10.1183/09031936.00122806.
31. Pierce, E. M., Carpenter, K., Jakubzick, C., Kunkel, S. L., Flaherty, K. R., Martinez, F. J., et al. (2007b). Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice. Am. J. Pathol. 170, 1152-1164. doi: 10.2353/ajpath.2007.060649.
32. Rangel-Moreno, J., Hartson, L., Navarro, C., Gaxiola, M., Selman, M., and Randall, T. D. (2006). Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J. Clin. Invest. 116, 3183-3194. doi: 10.1172/JCI28756.
33. Richards, C. D., Kerr, C., Tong, L., and Langdon, C. (2002). Modulation of extracellular matrix using adenovirus vectors. Biochem. Soc. Trans. 30, 107-111. doi: 10.1042/BST0300107.
34. Saito, F., Tasaka, S., Inoue, K. I., Miyamoto, K., Nakano, Y., Ogawa, Y., et al. (2007). Role of Interleukin-6 in Bleomycin-Induced Lung Inflammatory Changes in Mice. Am. J. Respir. Cell Mol. Biol. 38, 566-571. doi: 10.1165/rcmb.2007-0299OC.
35. Scaffidi, A. K., Mutsaers, S. E., Moodley, Y. P., Mcanulty, R. J., Laurent, G. J., Thompson, P. J., et al. (2002). Oncostatin M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts. Br. J. Pharmacol. 136, 793-801. doi: 10.1038/sj.bjp.0704769.
36. Schmidt, M., Sun, G., Stacey, M. A., Mori, L., and Mattoli, S. (2003). Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171, 380-389.
37. Shahar, I., Fireman, E., Topilsky, M., Grief, J., Kivity, S., Spirer, Z., et al. (1996). Effect of IL-6 on alveolar fibroblast proliferation in interstitial lung diseases. Clin. Immunol. Immunopathol. 79, 244-251. doi: 10.1006/clin.1996.0075.
38. Shoda, H., Yokoyama, A., Nishino, R., Nakashima, T., Ishikawa, N., Haruta, Y., et al. (2007). Overproduction of collagen and diminished SOCS1 expression are causally linked in fibroblasts from idiopathic pulmonary fibrosis. Biochem. Biophys. Res. Commun. 353, 1004-1010. doi: 10.1016/j.bbrc.2006.12.128.
39. Takizawa, H., Satoh, M., Okazaki, H., Matsuzaki, G., Suzuki, N., Ishii, A., et al. (1997). Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: correlation with the clinical parameters. Clin. Exp. Immunol. 107, 175-181. doi: 10.1046/j.1365-2249.1997.d01-905.x.
40. Trujillo, G., Hartigan, A. J., and Hogaboam, C. M. (2010a). T regulatory cells and attenuated bleomycin-induced fibrosis in lungs of CCR7-/-mice. Fibrogenesis Tissue Repair 3:18. doi: 10.1186/1755-1536-3-18.
41. Trujillo, G., Meneghin, A., Flaherty, K., and Al, E. (2010b). TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis. Sci. Transl. Med. 2:57ra82. doi: 10.1126/scitranslmed.3001510.
42. Wallace, W. A., Howie, S. E., Krajewski, A. S., and Lamb, D. (1996). The immunological architecture of B-lymphocyte aggregates in cryptogenic fibrosing alveolitis. J. Pathol. 178, 323-329. doi: 10.1002/(SICI)1096-9896(199603)178:3<323::AID-PATH467>3.0.CO;2-7.
43. Wolters, P. J., Collard, H. R., and Jones, K. D. (2013). Pathogenesis of idiopathic pulmonary fibrosis. Annu. Rev. Pathol. doi: 10.1146/annurev-pathol-012513-104706 [Epub ahead of print].
44. Wynn, T. A. (2011). Integrating mechanisms of pulmonary fibrosis. J. Exp. Med. 208, 1339-1350. doi: 10.1084/jem.20110551.
45. Xu, D., and Qu, C. K. (2008). Protein tyrosine phosphatases in the JAK/STAT pathway. Front. Biosci. 13:4925-4932. doi: 10.2741/3051.
46. Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., et al. (2010). Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104-107. doi: 10.1038/nature08780.